Beryl Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Beryl Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-565,016	Closed	-$5.65M	–	209
2022 Q1	$5.65M	Hold	565,016	–	–	0.34%	118
2021 Q4	$5.59M	Buy	+565,016	New	+$5.58M	0.29%	130

Other funds holding IQMD

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Beryl Capital Management's IQMD Position: Q2 2022 in Review

Beryl Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2022, closing a stake of 565,016 shares — an estimated $5.65M sold.

Beryl Capital Management first reported a position in IQMD in Q4 2021 and held it in 2 quarters. The position peaked at $5.65M in Q1 2022. 58 funds tracked by Wall St. Rank hold IQMD as of Q2 2022.

Beryl Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Beryl Capital Management sold 565,016 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $5.65M.
Beryl Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 2 quarters.
Beryl Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $5.65M in Q1 2022.
58 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Beryl Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.